Skip to main content
OpenTrials

Clinical trial condition

Unresectable Malignant Solid Neoplasm

Explore clinical trials studying Unresectable Malignant Solid Neoplasm. Study availability and eligibility vary by location and protocol.

37 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Malignant Solid Neoplasm trial results

Active, Not Recruiting

Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors

NCT03030378

Conditions
Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, Neoplasms, +4 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02595931

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Colonic Diseases, +42 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer

NCT04294628

Conditions
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +6 more
Locations
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • NYP/Weill Cornell Medical Center New York, United States
View Trial Details

Related conditions